PHARMERICA CORPORATION (NYSE:PMC) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07
|
Submission of Matters to a Vote of Security Holders. |
The 2017 Annual Meeting of Stockholders of PharMerica Corporation
(the Company) was held on June 14, 2017.
1. |
The Companys stockholders approved the election of the
following seven directors for a term to expire at the Annual Meeting of Stockholders in 2018. The votes for each director were as follows: |
Name |
For |
Withheld Authority |
Broker Non- Votes |
|||||||||
|
Frank E. Collins, Esq. |
26,260,958
|
145,961
|
3,402,081
|
|||||||||
|
W. Robert Dahl, Jr. |
26,314,884
|
92,035
|
3,402,081
|
|||||||||
|
Marjorie W. Dorr |
26,322,611
|
84,308
|
3,402,081
|
|||||||||
|
Patrick G. LePore |
26,295,796
|
111,123
|
3,402,081
|
|||||||||
|
Geoffrey G. Meyers |
26,301,570
|
105,349
|
3,402,081
|
|||||||||
|
Robert A. Oakley, Ph.D. |
26,313,704
|
93,215
|
3,402,081
|
|||||||||
|
Gregory S. Weishar |
26,317,775
|
89,144
|
3,402,081
|
2. |
The Companys stockholders voted upon the ratification of
the appointment of KPMG LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017. The votes on this proposal were as follows: |
|
For |
Against |
Abstained |
||
|
29,719,945 |
81,839 |
7,216 |
3. |
The Companys stockholders voted upon and approved, by
advisory vote, the compensation of the Companys named executive officers. The votes on this proposal were as follows: |
|
For |
Against |
Abstained |
Broker Non-Votes |
|||
|
25,173,015 |
1,181,809 |
52,095 |
3,402,081 |
4. |
The Companys stockholders voted upon and approved, by
advisory vote, one year as the frequency of the advisory vote on executive compensation in future years. The votes on this proposal were as follows: |
|
One Year |
Two Years |
Three Years |
Abstained |
Broker Non-Votes |
||||
|
19,874,255 |
11,468 |
6,475,964 |
45,232 |
3,402,081 |
5. |
The Companys stockholders voted upon and approved, by
advisory vote, a stockholder proposal regarding simple majority vote. The votes on this proposal were as follows: |
|
For |
Against |
Abstained |
Broker Non-Votes |
|||
|
23,545,772 |
2,803,577 |
57,570 |
3,402,081 |
About PHARMERICA CORPORATION (NYSE:PMC)
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.
